KRAS and neoplasm: Next, we compared the mutation rates of five of the most common driver mutations in LUAD, including EGFR, TP53, KRAS, STK11, and KEAP1, which were reported to be correlated with tumor antigenicity and immunogenicity (43, 45, 47, 48).